Literature DB >> 24210781

Coculture of peripheral blood CD34+ cell and mesenchymal stem cell sheets increase the formation of bone in calvarial critical-size defects in rabbits.

Guanghui Li1, Xi Wang2, Jian Cao3, Zhaoyu Ju4, Dongyang Ma3, Yanpu Liu5, Junrui Zhang6.   

Abstract

The reconstruction of large bony defects remains a clinical challenge, and angiogenesis and neovascularisation are being given more attention in bone tissue engineering. In this study we cocultured peripheral blood CD34+ cells (PB-CD34+ cells), an endothelial progenitor cell/haematopoietic stem cell-enriched population, with bone marrow-derived mesenchymal stem cells (MSC) to investigate their potential for bony regeneration. Cocultured cells showed better osteogenic differentiation than MSC alone in vitro. The cocultured cells and MSC sheets were also composited with hydroxyapatite and implanted in calvarial critical-size defects in rabbits. The rabbits were killed before microcomputed tomographic (MicroCT) and histological analysis. The results showed that cocultured cell composites had promoted bony regeneration more efficiently by 8 weeks after implantation. Our results indicate that the coculture of PB-CD34+ cells and MSC increases bony regeneration in calvarial critical-size defects in rabbits, and provide a new promising therapeutic strategy to aid skeletal healing.
Copyright © 2013 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bone regeneration; Cell sheet transplantation; Co-culture; Mesenchymal stem cells; Peripheral blood CD34+ cells; Rabbit calvarial critical-size defect

Mesh:

Substances:

Year:  2013        PMID: 24210781     DOI: 10.1016/j.bjoms.2013.10.004

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  8 in total

1.  Preformed Vascular Networks Survive and Enhance Vascularization in Critical Sized Cranial Defects.

Authors:  Brianna M Roux; Banu Akar; Wei Zhou; Katerina Stojkova; Beatriz Barrera; Jovan Brankov; Eric M Brey
Journal:  Tissue Eng Part A       Date:  2018-10-12       Impact factor: 3.845

2.  [Establishment and biological effect evaluation of prevascularized porous β-tricalcium phosphate tissue engineered bone].

Authors:  Mengquan Huang; Jian Fan; Ziyang Ma; Jing Li; Yajie Lu
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2022-05-15

3.  Features of a simvastatin-loaded multi-layered co-electrospun barrier membrane for guided bone regeneration.

Authors:  Dan Yu; Chongshang Huang; Chu Jiang; Huiyong Zhu
Journal:  Exp Ther Med       Date:  2021-05-03       Impact factor: 2.447

Review 4.  A Concise Review on the Use of Mesenchymal Stem Cells in Cell Sheet-Based Tissue Engineering with Special Emphasis on Bone Tissue Regeneration.

Authors:  A Cagdas Yorukoglu; A Esat Kiter; Semih Akkaya; N Lale Satiroglu-Tufan; A Cevik Tufan
Journal:  Stem Cells Int       Date:  2017-11-05       Impact factor: 5.443

Review 5.  Cross-Talk Between Mesenchymal Stromal Cells (MSCs) and Endothelial Progenitor Cells (EPCs) in Bone Regeneration.

Authors:  Cyril Bouland; Pierre Philippart; Didier Dequanter; Florent Corrillon; Isabelle Loeb; Dominique Bron; Laurence Lagneaux; Nathalie Meuleman
Journal:  Front Cell Dev Biol       Date:  2021-05-13

6.  Addition of Adipose-Derived Stem Cells to Mesenchymal Stem Cell Sheets Improves Bone Formation at an Ectopic Site.

Authors:  Zhifa Wang; Zhijin Li; Taiqiang Dai; Chunlin Zong; Yanpu Liu; Bin Liu
Journal:  Int J Mol Sci       Date:  2016-02-02       Impact factor: 5.923

Review 7.  A Narrative Review of Cell-Based Approaches for Cranial Bone Regeneration.

Authors:  Maria I Falguera Uceda; Silvia Sánchez-Casanova; Clara Escudero-Duch; Nuria Vilaboa
Journal:  Pharmaceutics       Date:  2022-01-05       Impact factor: 6.321

8.  Impact of Endothelial Progenitor Cells in the Vascularization of Osteogenic Scaffolds.

Authors:  Dominik Steiner; Lea Reinhardt; Laura Fischer; Vanessa Popp; Carolin Körner; Carol I Geppert; Tobias Bäuerle; Raymund E Horch; Andreas Arkudas
Journal:  Cells       Date:  2022-03-08       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.